Embrex will build a biological manufacturing facility near Laurinburg, the company said late Monday.

Although final details have yet to be worked out, Embrex said the facility should be built within the next year and will employ an estimated 40 people.

Embrex said the plant will be used to manufacture its Ovo Coccidiosis vaccine. The disease attacks chickens’ digestive systems. The drug Inovocox is currently under review by the Federal Drug Administration.

Embrex: www.embrex.com